TECH BUYER Dec 2022 - IDC MarketScape - Doc # US43720718
IDC MarketScape: U.S. RCM Product Solutions 2022-2023 Vendor Assessment
Abstract
This IDC study assesses revenue cycle management (RCM) product solutions currently available in the U.S. market. This study aims to provide technology buyers with insight into the strategies, capabilities, and criteria that healthcare organizations should consider when selecting an RCM product solution.
"Many providers do not have a clear idea of what revenue cycle product solutions are out there, better yet the value and benefits these can deliver to their organizations," says Mutaz Shegewi, research director, Worldwide Provider IT Transformation Strategies at IDC. "This is a new day and age for healthcare where the lines between providers and payers are blurrier than ever. RCM product solutions play an important role in ensuring that providers can better manage their revenue cycles from end to end and introduce next-generational capabilities that translate the technology investment into value not only through an impact on the bottom line but through better experiences for staff and patients as well."
Coverage
Subscriptions Covered
IDC Health Insights: Worldwide Healthcare Provider Digital Strategies
Companies Covered
NextGen RCM Services, LLC, Oracle Corporation, Experian plc, Cognizant Technology Solutions Corporation, RevPoint Media, Optum, Inc., Availity LLC, Change Healthcare LLC, WAYSTAR TECHNOLOGIES, INC., Allscripts Healthcare LLC, Athenahealth, Inc., LAS CLAIMS MANAGEMENT LIMITED, GATEWAY EDI, INC. (FKA: OFFICE TECH), FinThrive Revenue Systems LLC, Kyruus, Inc., Epic Systems Corporation, META HEALTHCARE IT SOLUTIONS LLC, eClinicalWorks, LLC, RevSpring Inc., CompuGroup Medical AG
Regions Covered
Topics Covered
Analytic applications, Cognitive/artificial intelligence, Collaborative applications, Financial resource management, Technology buyer
Vertical Markets
Healthcare strategies, Value-based health
Content
List of Tables
List of Figures
Get More
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.